Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
8.68
+0.36 (4.33%)
Apr 13, 2026, 10:35 AM EDT - Market open
Seres Therapeutics Employees
Seres Therapeutics had 66 employees as of December 31, 2025. The number of employees decreased by 37 or -35.92% compared to the previous year.
Employees
66
Change (1Y)
-37
Growth (1Y)
-35.92%
Revenue / Employee
$11,955
Profits / Employee
$86,303
Market Cap
83.21M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 66 | -37 | -35.92% |
| Dec 31, 2024 | 103 | -130 | -55.79% |
| Dec 31, 2023 | 233 | -198 | -45.94% |
| Dec 31, 2022 | 431 | 98 | 29.43% |
| Dec 31, 2021 | 333 | 178 | 114.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| PolyPid | 75 |
| aTyr Pharma | 60 |
| Pliant Therapeutics | 49 |
| NeurAxis | 24 |
| Gain Therapeutics | 21 |
| Filana Therapeutics | 20 |
| Cognition Therapeutics | 14 |
MCRB News
- 4 days ago - Seres Therapeutics to Present at CARB-X Investor Day - GlobeNewsWire
- 4 weeks ago - Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 5 weeks ago - Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates - GlobeNewsWire
- 2 months ago - Seres Therapeutics Pauses Key Drug Study, Cuts Jobs To Save Cash - Benzinga
- 2 months ago - Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases - GlobeNewsWire
- 3 months ago - Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy - GlobeNewsWire
- 5 months ago - Seres Therapeutics to Participate in Piper Sandler Healthcare Conference - GlobeNewsWire
- 5 months ago - Seres Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire